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ORIGINAL ARTICLE

Psychological Problems Among Patients With Chronic Medical Disorders
During the COVID-19 Pandemic
Ali Akbar Asadi-Pooya1,2, Seyed Ali Nabavizadeh1, Saeid Sadeghian3, Mina Shahisavandi1, Zohreh Barzegar1, Abdullah
Nezafat1, Nahid Ashjazadeh1, Hamed Bazrafshan Drissi4, Ali Sahraian1
1
2
3

Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, USA

Department of Pediatric Neurology, Golestan Medical, Educational, and Research Center, Ahvaz Jundishapur University of Medical Sciences,
Ahvaz, Iran
4

Department of Cardiovascular, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Received: 02 Dec. 2020; Accepted: 18 Jun. 2021

Abstract- The aim of the current study was to investigate the rates of stress, anxiety, and depression among
people in south Iran (a group from the general population without a history of any chronic medical problems,
and cohorts of patients were recruited from epilepsy, diabetes, and cardiac disease clinics). We surveyed a
sample of people during September 2020: a group of the general population without a history of any chronic
medical problems, people with epilepsy, people with diabetes mellitus (DM), and people with cardiac problems.
The survey included four general questions and two COVID-19 specific questions [contracting COVID-19,
relatives with COVID-19]. Furthermore, the survey included the DASS (Depression-Anxiety-Stress Scale)-21
questionnaire. 487 people were surveyed (154 people with epilepsy, 127 patients with DM, 98 people with
cardiac problems, and 108 healthy individuals). Among people without a history of any chronic medical
illnesses, 14% had any psychological problems. The highest rates of depression and anxiety were observed
among patients with DM (52% and 57%, respectively), and the highest rate of increased stress was observed
among people with cardiac problems (40%). The existence of any underlying medical problem was significantly
associated with higher rates of depression, anxiety, and stress among the participants. While many patients with
underlying chronic medical conditions suffer from depression, anxiety, and stress during the COVID-19
pandemic, we cannot establish a cause and effect relationship between the COVID-19 pandemic and increased
psychological problems among these patients.
© 2021 Tehran University of Medical Sciences. All rights reserved.
Acta Med Iran 2021;59(6):322-326.
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Introduction
Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused a catastrophic pandemic
(COVID-19) since late 2019 (1). This virus is highly
contagious and has a high potential for human-to-human
transmission. It may cause a severe and fatal illness
characterized by acute respiratory distress syndrome,
multi-organ failure, and death (1). However, in addition
to the physical health hazards of this viral infection, the
psychological impacts of the COVID-19 pandemic on

different groups of people should also be taken into
account seriously (2,3). Mental health issues such as
stress, anxiety, depression, frustration, and uncertainty
have emerged progressively during the COVID-19
outbreak. Similarly, studies performed on the
psychological impacts of previous infectious outbreaks,
such as the severe acute respiratory syndrome (SARS),
have found significant psychological problems (e.g.,
anxiety, depression, or stress) among the public during
the outbreak (4).
Major risk factors for a more severe illness due to
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COVID-19 have been identified as older age and
underlying chronic medical disorders, among others
(1,5,6). Cerebrovascular diseases (odds ratio [OR]: 3.66),
chronic obstructive pulmonary disease (OR: 2.39),
cardiovascular diseases (OR: 2.84), diabetes mellitus
(DM) (OR: 2.78), and hypertension (OR: 2.24) have been
associated with severe COVID-19 (5). Therefore, it is
plausible to assume that people with chronic medical
problems are also at higher risk of experiencing undue
stress, anxiety, and depression compared with that in the
general public due to the fear of contracting a more severe
illness and its potential consequences.
The aim of the current study was to investigate the
rates of stress, anxiety, and depression among people in
south Iran. We investigated four groups of people in order
to clarify the psychological impacts of the COVID-19
pandemic on different groups of patients with underlying
medical problems; a group from the general population
without a history of any chronic medical problems,
patients with epilepsy, patients with DM, and patients
with cardiac problems. We hypothesized that the rates of
stress, anxiety, and depression are significantly higher
among patients with the chronic medical condition
compared with those among healthy individuals.

Materials and Methods
Participants
In this cross-sectional study, we surveyed four groups
of people during September 2020: a group of the general
population from Shiraz (a major city in south Iran)
without a history of any chronic medical problems
selected randomly, patients with epilepsy (referring
consecutively to the neurology clinic at Shiraz University
of Medical Sciences), patients with DM (referring
consecutively to the DM clinic at Shiraz University of
Medical Sciences), and patients with chronic cardiac
problems (referring consecutively to the cardiology clinic
at Shiraz University of Medical Sciences). The inclusion
criteria were adults (> 18 years) and literacy (> 5 years of
education). The exclusion criteria included intellectual
disability and unwillingness to participating in the study.
Instruments
The survey included four general questions [age, sex,
education (school vs. college), and medical/psychiatric
problems]. It also included two COVID-19 specific
questions [contracting COVID-19 (self-declared),
relatives (i.e., spouse, children, siblings, parents) with
COVID-19 (self-declared)]. Furthermore, the survey
included the DASS (Depression-Anxiety-Stress Scale)-

21 questionnaire (Appendix 1). In this short version of the
DASS questionnaire, each item (depression, anxiety, and
stress) is assessed by seven questions. The DASS-21
scale has been translated and validated in the Farsi
language (7).
Statistical analyses
Statistical analyses were performed using the
independent t-test, Fisher’s Exact test, Pearson chi-square
test, and Bonferroni correction test. Moderate, severe, or
extremely
severe
depression/anxiety/stress
was
considered as the existence of a psychological burden (vs.
normal and mild scores). Variables with a P<0.1 in
univariate tests were assessed in a logistic regression
model. Odds ratio (OR) and 95% confidence interval (CI)
were calculated. A P (2-sided) less than 0.05 was
considered significant.

Results
The total number of the participants was 487 people
[154 patients with epilepsy (66 men and 88 women), 127
patients with DM (40 men and 68 women), 98 patients
with cardiac problems (54 men and 44 women), and 108
healthy individuals (66 men and 88 women)]. The mean
age of the participants was 37 years (standard deviation:
16 years) (range: 18 to 97 years). The mean age of the
groups differed significantly (27±9 years in controls,
33±12 years in the epilepsy group, 43±18 years among
patients with DM, and 50±15 years among those with
cardiac problems; P=0.0001). They included 271 females
and 216 males. The sex ratios of the groups were not
significantly different (P=0.07).
Moderate, severe, or extremely severe depression was
observed among 33% of the participants (160 people).
Moderate, severe, or extremely severe anxiety was
observed among 41% of the participants (201 people).
Moderate, severe, or extremely severe stress was
observed among 29% of the participants (139 people).
Table 1 shows the factors associated with
depression/anxiety/stress in univariate analysis. The
existence of an underlying medical disorder was
consistently associated with higher rates of depression,
anxiety, and stress among the studied participants
(compared with that in healthy individuals). Among
people without a history of any chronic medical illnesses,
these rates were 14% for all three psychological problems
(depression/anxiety/stress). The highest rates of
depression and anxiety were observed among patients
with DM (52% and 57%, respectively); patients with
epilepsy had a risk less than those with DM and more than
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patients with cardiac problems. The highest rate of
increased stress was observed among patients with
cardiac problems (40%); patients with epilepsy had a risk
lower than those with DM and also patients with cardiac
problems.
We then analyzed the association between
depression/anxiety/stress and variables with a P<0.1 in a
binary logistic regression model. The models that were
generated by regression analysis were significant

(P=0.0001). Table 2 shows the results of these analyses.
The existence of an underlying medical problem was
significantly associated with higher rates of depression,
anxiety, and stress among the participants (with robust
ORs). Female sex was significantly associated with
higher rates of depression and anxiety (with modest ORs).
A history of relatives with COVID-19 was significantly
associated with higher rates of depression (with a modest
OR) (Table 2).

Table 1. Factors associated with depression/anxiety/stress in univariate analysis
Depression
With (N=160)
Sex (Female: Male)
Mean age ± Standard deviation (years)
Education (college)
Medical problem (none, epilepsy, diabetes,
cardiac)
Relatives with COVID-19
History of COVID-19
Anxiety
Sex (Female: Male)
Mean age ± Standard deviation (years)
Education (college)
Medical problem (none, epilepsy, diabetes,
cardiac)
Relatives with COVID-19
History of COVID-19
Stress
Sex (Female: Male)
Mean age ± Standard deviation (years)
Education (college)
Medical problem (none, epilepsy, diabetes,
cardiac)
Relatives with COVID-19
History of COVID-19

Without (N=327)

P

df

100: 60
40 ± 16
58 (36%)

171: 156
36 ± 16
131 (40%)

0.041
0.038
0.428

1
485
1

15 (14%), 50 (32%), 66 (52%), 29
(30%)

93 (86%), 104 (68%), 61 (48%), 69
(70%)

0.0001

3

36 (23%)
13 (8%)

50 (15%)
29 (9%)

0.058
0.865

1
1

With (N=201)

Without (N=286)

P

df

121: 80
39 ± 16
72 (36%)

150: 136
36 ± 16
117 (41%)

0.096
0.073
0.257

1
485
1

15 (14%), 78 (51%), 73 (57%), 35
(36%)

93 (86%), 76 (49%), 54 (43%), 63
(64%)

0.0001

3

41 (20%)
14 (7%)

45 (16%)
28 (10%)

0.187
0.326

1
1

With (N=139)

Without (N=348)

P

df

84: 55
41 ± 16
44 (32%)

187: 161
36 ± 16
145 (42%)

0.190
0.003
0.039

1
485
1

15 (14%), 38 (25%), 47 (37%), 39
(40%)

93 (86%), 116 (75%), 80 (63%), 59
(60%)

0.0001

3

31 (22%)
12 (8%)

55 (16%)
30(9%)

0.114
1.000

1
1

*After Bonferroni correction, a significant predictive value is 0.008. The significant P is in bold. df: degree of freedom

Table 2. Factors associated with depression/anxiety/stress in logistic regression models (compared with
healthy individuals)
Odds Ratio
Medical problem (epilepsy/
diabetes/
cardiac)
Sex (Female)
Relatives with COVID-19
Age

Depression
95% confidence interval

P

df

3.13/
6.96/

1.63-6.03/
3.49-13.93/

0.001/
0.0001/

1

2.89

1.32-6.30

0.007

1.72
1.71

1.14- 2.59
1.03-2.85

0.010
0.038
0.731

1
1
1

6.52/
8.48/

3.44-12.36/
4.27-16.85/

0.0001/
0.0001/

1

3.56

1.67-7.58

0.001

1.51

1.02- 2.36

0.038
0.756

1
1

1.90/
3.25/

0.95-3.77/
1.61-6.57/

0.066/
0.001/

1

3.56

1.64-7.69

0.001

Anxiety
Medical problem (epilepsy/ diabetes/
cardiac)
Sex (Female)
Age

Stress
Medical problem (epilepsy/ diabetes/
cardiac)

Age
Education (college)
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0.611
0.525
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Discussion
In this cross-sectional study, we observed that many
patients with various underlying chronic medical
conditions suffer from depression, anxiety, and stress
during the COVID-19 pandemic. In a national face-toface household survey from Iran that was published five
years ago, the most common category of psychiatric
disorders was any anxiety disorder (15.6%), and the most
prevalent particular disorder was major depressive
disorder (12.7%) (8). These rates are comparable with
what we observed among the healthy individuals in the
current study (14% for both depression and anxiety).
Furthermore, in studies from the pre-COVID era in Iran,
the prevalence of depression among Iranian patients with
DM was estimated to be 62% (95% confidence interval
[CI]: 57-67), and the prevalence of anxiety among Iranian
patients with DM was estimated to be 65% (95% CI: 4282) (9). The prevalence of depression among
cardiovascular patients in Iran was estimated to be 47%
(95% CI: 38-56) in one study (10). Finally, in one crosssectional hospital-based study of 74 adults with epilepsy,
26 (35%) patients had symptoms of depression (11).
These rates are also comparable with what we observed
among patients with DM, cardiovascular disorders, and
epilepsy in the current study.
Therefore, while we observed that many patients with
underlying chronic medical conditions (i.e., epilepsy,
DM, and cardiovascular disorders) suffer from
depression, anxiety, and stress during the COVID-19
pandemic, we cannot establish or even hypothesize a
cause and effect relationship between COVID-19
pandemic and increased psychological burden and
problems among these patients based on the current
study. However, the prevalence of depressive and anxiety
symptoms was reported to be significantly higher in the
UK, relative to pre-pandemic epidemiological data (12).
This cross-cultural difference should be studied more in
the future.
We can provide the following speculation to explain
our counterintuitive findings described above. The
general public in Iran has already been under tremendous
psychological pressure due to various reasons (e.g.,
economic, political, etc.) (13). On top of that, patients
with chronic medical problems (e.g., epilepsy, DM, etc.)
in Iran may suffer from psychological disorders as a
comorbidity to their underlying illness (as any other
person elsewhere in the world) (14) or because of the
existing undue pressure due to social reasons (e.g.,
shortage of their drugs due to economic sanctions) (13).

The interactions between chronic diseases and
psychological problems have been described in the
literature (15). However, why the COVID-19 pandemic
has not (significantly) worsened the already high rates of
psychological problems in Iran is an intriguing finding
that should be explored in future studies.
This study has some limitations. This was a crosssectional study, and we did not have the pre-pandemic
epidemiological data or mental health histories of the
participants. In addition, the groups differed with respect
to their age, and this might have affected the results.
Furthermore, we did not investigate the drug history (e.g.,
antidepressants) of the patients. Finally, the timing
between getting ill with COVID-19 (in the affected
people) and completing these questionnaires was not
recorded.
We can conclude that many patients with various
underlying chronic medical conditions suffer from
depression, anxiety, and stress during the COVID-19
pandemic. The observed high rates of depression,
anxiety, and stress in Iran (during the COVID-19
pandemic or at any other time), particularly among
patients with underlying medical problems, are alarming
and should be taken into account seriously. These
psychological problems (depression, anxiety, and stress)
are not only associated with impaired quality of life (16)
but also may affect the health status of the people and
even increase the risk of premature death (17). There are
various interventions available that may help reduce or
prevent depression, anxiety, and stress among the
affected people and also those at risk; health promotion
interventions, exercise, and yoga, are some examples (1820). Having said that, the key element is to screen the at
risk populations and detect any psychological problem as
soon as possible.
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